STOCK TITAN

TrueBlue (TBI) director awarded 29,607 RSUs, total deferred shares 85,000

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TrueBlue, Inc. director William C. Goings reported an equity award of 29,607 shares of Common Stock in the form of restricted stock units. These units vest in full one year from the grant date and will be settled one-for-one in shares after he leaves the Board.

Following this award, his reported holdings total 85,000 shares, which the footnotes state are deferred under the company’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. The award has no cash exercise price and represents additional long-term, stock-based compensation.

Positive

  • None.

Negative

  • None.

Insights

Routine RSU grant increases director’s deferred share holdings.

William C. Goings, a director of TrueBlue, Inc., received 29,607 restricted stock units, described as a grant or award with no purchase price. These units vest in one year and settle into Common Stock on a one-for-one basis after he leaves Board service.

The filing reports 85,000 total shares, with footnotes explaining these are deferred under the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. This points to standard, long-term equity-based compensation rather than an open-market transaction, so it is best viewed as an administrative update rather than a thesis-changing event.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Goings William C.

(Last) (First) (Middle)
1015 A STREET

(Street)
TACOMA WA 98402

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TrueBlue, Inc. [ TBI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/20/2026 A 29,607(1) A $0 85,000(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors.
2. This total includes 85,000 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.
Remarks:
/s/ Todd N. Gilman, Attorney-in-fact 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TrueBlue (TBI) director William C. Goings acquire in this Form 4?

William C. Goings received a grant of 29,607 restricted stock units tied to TrueBlue Common Stock. Each unit will convert into one share in the future, providing additional long-term equity compensation rather than an immediate open-market stock purchase.

When do William C. Goings’ new TrueBlue (TBI) restricted stock units vest?

The restricted stock units granted to William C. Goings vest in full one year from the grant date. This creates a short, defined vesting period before the award is fully earned, aligning director compensation with near-term Board service.

When will William C. Goings receive the vested TrueBlue (TBI) shares?

According to the filing, delivery of the vested shares will occur ninety days after his separation from service on the Board of Directors. This deferred delivery structure is part of TrueBlue’s approach to compensating non-employee directors with long-term equity exposure.

How many TrueBlue (TBI) shares does William C. Goings report owning after this grant?

After the reported grant, William C. Goings is shown as holding 85,000 shares of TrueBlue Common Stock. Footnotes explain these shares are deferred under the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors, rather than being directly held in a regular brokerage account.

Is William C. Goings’ TrueBlue (TBI) Form 4 a stock purchase or a compensation award?

The Form 4 describes this transaction as a grant or award acquisition of restricted stock units, not an open-market purchase. The units carry a zero dollar price per share, confirming they function as equity compensation for his role as a non-employee director.
Trueblue

NYSE:TBI

TBI Rankings

TBI Latest News

TBI Latest SEC Filings

TBI Stock Data

109.58M
28.43M
Staffing & Employment Services
Services-help Supply Services
Link
United States
TACOMA